References
- Antony J, Gopalan V, Smith RA, Lam AK. Carcinoma ex pleomorphic adenoma: A comprehensive review of clinical, pathological and molecular data. Head Neck Pathol. 2012;6:1-9.
- Di Palma S. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. Head Neck Pathol. 2013;7:S68-76. https://doi.org/10.1007/s12105-013-0454-z
- Luers JC, Wittekindt C, Streppel M, Guntinas-Lichius O. Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy. Acta Oncol. 2009;48:132-136. https://doi.org/10.1080/02841860802183604
- Altemani A, Martins MT, Freitas L, Soares F, Araujo NS, Araujo VC. Carcinoma ex pleomorphic adenoma (CXPA): Immunoprofile of the cells involved in carcinomatous progression. Histopathology. 2005;46:635-641. https://doi.org/10.1111/j.1365-2559.2005.02157.x
- Cormier C, Agarwal S. Myoepithelial Carcinoma Ex-pleomorphic Adenoma: A rare pathology misdiagnosed as pleomorphic adenoma; With a novel TERT promoter mutation and high PD-L1 expression. Head Neck Pathol. 2022;16:322-330. https://doi.org/10.1007/s12105-021-01346-0
- Logasundaram R, Amarawickrama H, Premachandra D, Hellquist H. Intracapsular (in situ) carcinoma ex pleomorphic adenoma with unusual clinical and histological features. Eur Arch Otorhinolaryngol. 2008;265:1563-1566. https://doi.org/10.1007/s00405-008-0615-y
- Zhao J, Wang J, Yu C, Guo L, Wang K, Liang Z, et al. Prognostic factors affecting the clinical outcome of carcinoma ex pleomorphic adenoma in the major salivary gland. World J Surg Oncol. 2013;11:180.
- Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D, et al. Management of salivary gland malignancy: ASCO guideline. J Clin Oncol. 2021;39:1909-1941. https://doi.org/10.1200/JCO.21.00449
- Skalova A, Hyrcza MD, Leivo I. Update from the 5th edition of the World Health Organization classification of head and neck tumors: Salivary glands. Head Neck Pathol. 2022;16:40-53. https://doi.org/10.1007/s12105-022-01420-1
- National Comprehensive Cancer Network. Head and neck cancer (Version 2.2023) [cited 2023 May 15]. Available from: URL: https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
- Nakamori K, Ohuchi T, Hasegawa T, Hiratsuka H. Carcinoma ex pleomorphic adenoma of the buccal region is composed of salivary duct carcinoma and squamous cell carcinoma components. Int J Oral Maxillofac Surg. 2009;38:1116-1118. https://doi.org/10.1016/j.ijom.2009.04.016
- Mantsopoulos K, Bessas Z, Sievert M, Muller SK, Koch M, Agaimy A, et al. Frozen section of parotid gland tumours: The head and neck pathologist as a key member of the surgical team. J Clin Med. 2022;11:1249. https://doi.org/10.3390/jcm11051249.
- Kim JW, Kwon GY, Roh JL, Choi SH, Nam SY, Kim SY, et al. Carcinoma ex pleomorphic adenoma of the salivary glands: Distinct clinicopathologic features and immunoprofiles between subgroups according to cellular differentiation. J Korean Med Sci. 2011;26:1277-1285. https://doi.org/10.3346/jkms.2011.26.10.1277
- Gilbert MR, Sharma A, Schmitt NC, Johnson JT, Ferris RL, Duvvuri U, et al. A 20-year review of 75 cases of salivary duct carcinoma. JAMA Otolaryngol Head Neck Surg. 2016;142:489-495. https://doi.org/10.1001/jamaoto.2015.3930
- Nakaguro M, Tada Y, Faquin WC, Sadow PM, Wirth LJ, Nagao T. Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol. 2020;128:693-703. https://doi.org/10.1002/cncy.22288